Camp4 Therapeutics (CAMP) Capital Expenditures (2023 - 2025)
Camp4 Therapeutics (CAMP) reported Capital Expenditures of $279000.0 for Q2 2025, up 933.33% on a YoY basis from $27000.0 in Q2 2024, and up 6.08% sequentially from $263000.0 in Q4 2024.
Camp4 Therapeutics (CAMP) Capital Expenditures (2023 - 2025) Analysis & Trends
Camp4 Therapeutics (CAMP) has 3 years of Capital Expenditures data on file, last reported at $279000.0 in Q2 2025.
- For the quarter ending Q2 2025, Capital Expenditures rose 933.33% year-over-year to $279000.0; the trailing twelve-month figure through Mar 2026 stood at $279000.0 (down 3.79% YoY), and the FY2025 full-year result was $279000.0, down 36.73% from the prior year.
- Capital Expenditures advanced to $279000.0 in Q2 2025, from $263000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $622000.0 in Q4 2023 to a low of $27000.0 in Q2 2024.
- A 3-year average of $268400.0 and a median of $263000.0 in 2024 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures plunged 57.72% in 2024 and jumped 933.33% in 2025, its largest moves.
- Tracing CAMP's Capital Expenditures over 3 years: stood at $622000.0 in 2023, then sank by 57.72% to $263000.0 in 2024, then rose by 6.08% to $279000.0 in 2025.
- Business Quant data shows CAMP's Capital Expenditures at $279000.0 in Q2 2025, $263000.0 in Q4 2024, and $27000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 279,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Dec 31, 2023 | 622,000.00 |
| Dec 31, 2023 | 622,000.00 |